Research Article
BibTex RIS Cite

RISK FACTORS FOR CATHETER DYSFUNCTION IN PATIENTS WITH TUNNELED HEMODIALYSIS CATHETERS

Year 2021, , 422 - 428, 04.08.2021
https://doi.org/10.18229/kocatepetip.901858

Abstract

OBJECTIVE: Tunneled hemodialysis catheter (THC) application is a common method for providing access to hemodialysis. There are early and late complications of catheter application, and it is very important to ensure the longevity of the catheter. The aim of the study was to evaluate the catheter patency in patients who underwent THC.
MATERIAL AND METHODS: The data of 221 catheter applications of 181 patients who underwent THC implantation in our hospital between January 2019 and December 2020 were analyzed retrospectively. Patient data regarding the reasons for catheter application, application areas, usage periods, developing early and late period complications and other accompanying system diseases in the patients were evaluated by scanning them from the hospital information and automation system.
RESULTS: Right internal jugular vein was the most preferred THC application site with a rate of 44.3% (98 applications). One or more catheter applications were performed in 28 patients (15.5%) due to catheter dysfunction. In the evaluation of the relationship between catheter dysfunction and the catheter application site, the rate of catheter dysfunction was found to be higher in common femoral venous access applications (p=0.002). No significant relationship was found between diabetes mellitus, malignancies, chronic obstructive pulmonary disease and coronary artery disease, cerebrovascular event, hypertension and catheter dysfunction. A significant increase in catheter dysfunction was detected in patients with atrial fibrillation (p=0.017).
CONCLUSIONS: THCs can be preferred in hemodialysis patients due to their ease of application and low complication rate. In these patients, the priority should be the upper extremity subclavian vein and the internal jugular vein in the choise of central venous access route. Femoral venous catheter application should be avoided unless required.

References

  • 1. Porazko T, Hobot J, Ziembik Z et al. Tunnelled haemodialysis catheter removal: An underappreciated problem, not always simple and safe. Int J Environ Res Public Health. 2020;17(9):3027.
  • 2. Kirişçi M, Güzel FB, Işıktaş S ve ark. Hemodiyaliz hastasında kateter ilişkili intraatrial enfekte trombus. Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi. 2017;12(2):31-3.
  • 3. Sevil FC, Tort M, Yıldız Z et al. Successful percutaneous removal of retained J-tip guidewire: A report of two cases. Turkish J Vasc Surg. 2020;29(1):66-9.
  • 4. Wilmink T. Vascular Access: Clinical practice guidelines of the European Society for Vascular Surgery. Eur J Vasc Endovasc Surg. 2018;55:753-4.
  • 5. DOQI Clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. AJKD. 2007;49(2):12-154.
  • 6. Lok CE, Huber TS, Lee T. KDOQI Clinical practice guideline for vascular access: 2019 update. Am J Kidney Dis. 2020;75-4(2):1-164.
  • 7. Sevil FC. Hastanemizde intravenöz yolla yerleştirilen implante edilebilir venöz erişim portu uygulamalarının sonuçları. Kocatepe Tıp Dergisi. 2020;21:345-52.
  • 8. Sevil FC, Tort M. Management of endovascular treatment in spontaneous iliac artery dissections: Applications enabling classical surgery. Turkish J Thorac Cardiovasc Surg. 2020;28(4):601-8.
  • 9. Weber E, Liberek T, Wołyniec W et al. Catheter tip malposition after percutaneous placement of tunneled hemodialysis catheters. Hemodial Int. 2015;19(4):509-13.
  • 10. Bhutta ST, Culp WC. Evaluation and management of central venous access complications. Tech Vasc Interv Radiol. 2011;14(4):217-24.
  • 11. Agarwal AK, Haddad N, Boubes K. Avoiding problems in tunneled dialysis catheter placement. Seminars in Dialysis. 2019;32(6):535-40.
  • 12. Vats HS. Complications of catheters: Tunneled and nontunneled. Adv Chronic Kidney Dis. 2012;19(3):188-94.
  • 13. Poinen K, Quinn RR, Clarke A et al. Complications from tunneled hemodialysis catheters: A Canadian observational cohort study. Am J Kidney Dis. 2019;73(4):467-75.
  • 14. Coker MA, Black JR, Li Y et al. An analysis of potential predictors of tunneled hemodialysis catheter infection or dysfunction. J Vasc Access. 2019;20(4):380-5.
  • 15. Herrington WG, Niye HJ, Haynes RJ et al. Does prophylactic anticoagulation reduce the risk of femoral tunneled dialysis catheter-related complications? Journal of Vascular Access. 2013; 14(2): 135-42.
  • 16. Parekh VB, Niyyar VD, Vachharajani TJ. Lower Extremity Permanent Dialysis Vascular Access. Clin J Am Soc Nephrol. 2016 Sep. 7;11(9):1693-702.
  • 17. Falk A. Use of the femoral vein as insertion site for tunneled hemodialysis catheters. J Vasc Interv Radiol. 2007;18(2):217-25.
  • 18. Shafique MN, Akhtar SH, Mahnoor M, et al. Hemodialysis Internal jugular vein versus Subclavian vein Catheters: Complications, patients' comfort, tolerance and cost- effectiveness. Pak J Med Sci. 2019;35(1):124-8.
  • 19. Bălăceanu A. Right atrium thrombosis in nonvalvular permanent atrial fibrillation. J Med Life. 2011;14(4):352-5.
  • 20. T. Sahin, Ural D, Kilic T et al. Right atrial appendage function in different etiologies of permanent atrial fibrillation: A transesophageal echocardiography and tissue doppler imaging study. Echocardiography. 2010;27(4):384-93.

TÜNELLİ HEMODİYALİZ KATETERLERİ OLAN HASTALARDA KATETER DİSFONKSİYONU İÇİN RİSK FAKTÖRLERİ

Year 2021, , 422 - 428, 04.08.2021
https://doi.org/10.18229/kocatepetip.901858

Abstract

AMAÇ: Tünelli hemodiyaliz kateter (THC) uygulaması, hemodiyaliz için erişim yolu sağlamada yaygın kullanılan bir metottur. Kateter uygulamasının erken ve geç dönem komplikasyonları mevcut olup, kateterin uzun ömürlülüğünün sağlanması çok önemlidir. THC uygulanan hastalarda kateter açıklığının değerlendirilmesi çalışmanın amacını oluşturmuştur.
GEREÇ VE YÖNTEM: Ocak 2019 ve Aralık 2020 tarihleri arasında hastanemizde THC implantasyonu yapılan 181 hastaya ait 221 kateter uygulamasının verileri retrospektif olarak analiz edildi. Kateter uygulama nedenleri, uygulama bölgeleri, kullanım süreleri, gelişen erken ve geç dönem komplikasyonları ve hastalarda eşlik eden diğer sistem hastalıklarına ait hasta verileri hastane bilgi ve otomasyon sisteminden taranarak değerlendirildi.
BULGULAR: Sağ internal juguler ven %44,3 (98 uygulama) oranıyla en sık tercih edilen THC uygulama bölgesiydi. 28 hastada (%15.5) kateter disfonksiyonu nedenli bir ya da daha fazla sayıda kateter uygulaması yapılmıştır. Kateter disfonksiyonu ile kateter uygulama bölgesi arasındaki ilişkinin değerlendirmesinde ana femoral venöz yol uygulamalarında kateter disfonksiyon oranı daha yüksek saptanmıştır (p=0.002). Diyabetes mellitus maligniteler, kronik obstrüktif akciğer hastalığı ve koroner arter hastalığı, serebrovaskuler olay, hipertansiyon ile kateter disfonksiyonu arasında anlamlı bir ilişki saptanmadı. Atrial fibrilasyonu olan hastalarda kateter disfonksiyonunda anlamlı olarak artış saptanmıştır (p=0.017).
SONUÇ: THC’leri hemodiyaliz hastalarında uygulama kolaylığı ve düşük komplikasyon oranı ile tercih edilebilir. Bu hastalarda santral venöz girişim yolu seçiminde öncelik üst ekstremite subklavyen ven ve internal juguler ven olmalıdır. Zorunda kalmadıkça femoral venöz kateter uygulamasından kaçınılmalıdır.

References

  • 1. Porazko T, Hobot J, Ziembik Z et al. Tunnelled haemodialysis catheter removal: An underappreciated problem, not always simple and safe. Int J Environ Res Public Health. 2020;17(9):3027.
  • 2. Kirişçi M, Güzel FB, Işıktaş S ve ark. Hemodiyaliz hastasında kateter ilişkili intraatrial enfekte trombus. Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi. 2017;12(2):31-3.
  • 3. Sevil FC, Tort M, Yıldız Z et al. Successful percutaneous removal of retained J-tip guidewire: A report of two cases. Turkish J Vasc Surg. 2020;29(1):66-9.
  • 4. Wilmink T. Vascular Access: Clinical practice guidelines of the European Society for Vascular Surgery. Eur J Vasc Endovasc Surg. 2018;55:753-4.
  • 5. DOQI Clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. AJKD. 2007;49(2):12-154.
  • 6. Lok CE, Huber TS, Lee T. KDOQI Clinical practice guideline for vascular access: 2019 update. Am J Kidney Dis. 2020;75-4(2):1-164.
  • 7. Sevil FC. Hastanemizde intravenöz yolla yerleştirilen implante edilebilir venöz erişim portu uygulamalarının sonuçları. Kocatepe Tıp Dergisi. 2020;21:345-52.
  • 8. Sevil FC, Tort M. Management of endovascular treatment in spontaneous iliac artery dissections: Applications enabling classical surgery. Turkish J Thorac Cardiovasc Surg. 2020;28(4):601-8.
  • 9. Weber E, Liberek T, Wołyniec W et al. Catheter tip malposition after percutaneous placement of tunneled hemodialysis catheters. Hemodial Int. 2015;19(4):509-13.
  • 10. Bhutta ST, Culp WC. Evaluation and management of central venous access complications. Tech Vasc Interv Radiol. 2011;14(4):217-24.
  • 11. Agarwal AK, Haddad N, Boubes K. Avoiding problems in tunneled dialysis catheter placement. Seminars in Dialysis. 2019;32(6):535-40.
  • 12. Vats HS. Complications of catheters: Tunneled and nontunneled. Adv Chronic Kidney Dis. 2012;19(3):188-94.
  • 13. Poinen K, Quinn RR, Clarke A et al. Complications from tunneled hemodialysis catheters: A Canadian observational cohort study. Am J Kidney Dis. 2019;73(4):467-75.
  • 14. Coker MA, Black JR, Li Y et al. An analysis of potential predictors of tunneled hemodialysis catheter infection or dysfunction. J Vasc Access. 2019;20(4):380-5.
  • 15. Herrington WG, Niye HJ, Haynes RJ et al. Does prophylactic anticoagulation reduce the risk of femoral tunneled dialysis catheter-related complications? Journal of Vascular Access. 2013; 14(2): 135-42.
  • 16. Parekh VB, Niyyar VD, Vachharajani TJ. Lower Extremity Permanent Dialysis Vascular Access. Clin J Am Soc Nephrol. 2016 Sep. 7;11(9):1693-702.
  • 17. Falk A. Use of the femoral vein as insertion site for tunneled hemodialysis catheters. J Vasc Interv Radiol. 2007;18(2):217-25.
  • 18. Shafique MN, Akhtar SH, Mahnoor M, et al. Hemodialysis Internal jugular vein versus Subclavian vein Catheters: Complications, patients' comfort, tolerance and cost- effectiveness. Pak J Med Sci. 2019;35(1):124-8.
  • 19. Bălăceanu A. Right atrium thrombosis in nonvalvular permanent atrial fibrillation. J Med Life. 2011;14(4):352-5.
  • 20. T. Sahin, Ural D, Kilic T et al. Right atrial appendage function in different etiologies of permanent atrial fibrillation: A transesophageal echocardiography and tissue doppler imaging study. Echocardiography. 2010;27(4):384-93.
There are 20 citations in total.

Details

Primary Language Turkish
Subjects Clinical Sciences
Journal Section Articles
Authors

Mehmet Tort 0000-0001-8414-3751

Publication Date August 4, 2021
Acceptance Date June 21, 2021
Published in Issue Year 2021

Cite

APA Tort, M. (2021). TÜNELLİ HEMODİYALİZ KATETERLERİ OLAN HASTALARDA KATETER DİSFONKSİYONU İÇİN RİSK FAKTÖRLERİ. Kocatepe Tıp Dergisi, 22(5), 422-428. https://doi.org/10.18229/kocatepetip.901858
AMA Tort M. TÜNELLİ HEMODİYALİZ KATETERLERİ OLAN HASTALARDA KATETER DİSFONKSİYONU İÇİN RİSK FAKTÖRLERİ. KTD. August 2021;22(5):422-428. doi:10.18229/kocatepetip.901858
Chicago Tort, Mehmet. “TÜNELLİ HEMODİYALİZ KATETERLERİ OLAN HASTALARDA KATETER DİSFONKSİYONU İÇİN RİSK FAKTÖRLERİ”. Kocatepe Tıp Dergisi 22, no. 5 (August 2021): 422-28. https://doi.org/10.18229/kocatepetip.901858.
EndNote Tort M (August 1, 2021) TÜNELLİ HEMODİYALİZ KATETERLERİ OLAN HASTALARDA KATETER DİSFONKSİYONU İÇİN RİSK FAKTÖRLERİ. Kocatepe Tıp Dergisi 22 5 422–428.
IEEE M. Tort, “TÜNELLİ HEMODİYALİZ KATETERLERİ OLAN HASTALARDA KATETER DİSFONKSİYONU İÇİN RİSK FAKTÖRLERİ”, KTD, vol. 22, no. 5, pp. 422–428, 2021, doi: 10.18229/kocatepetip.901858.
ISNAD Tort, Mehmet. “TÜNELLİ HEMODİYALİZ KATETERLERİ OLAN HASTALARDA KATETER DİSFONKSİYONU İÇİN RİSK FAKTÖRLERİ”. Kocatepe Tıp Dergisi 22/5 (August 2021), 422-428. https://doi.org/10.18229/kocatepetip.901858.
JAMA Tort M. TÜNELLİ HEMODİYALİZ KATETERLERİ OLAN HASTALARDA KATETER DİSFONKSİYONU İÇİN RİSK FAKTÖRLERİ. KTD. 2021;22:422–428.
MLA Tort, Mehmet. “TÜNELLİ HEMODİYALİZ KATETERLERİ OLAN HASTALARDA KATETER DİSFONKSİYONU İÇİN RİSK FAKTÖRLERİ”. Kocatepe Tıp Dergisi, vol. 22, no. 5, 2021, pp. 422-8, doi:10.18229/kocatepetip.901858.
Vancouver Tort M. TÜNELLİ HEMODİYALİZ KATETERLERİ OLAN HASTALARDA KATETER DİSFONKSİYONU İÇİN RİSK FAKTÖRLERİ. KTD. 2021;22(5):422-8.

88x31.png
Bu Dergi Creative Commons Atıf-GayriTicari-AynıLisanslaPaylaş 4.0 Uluslararası Lisansı ile lisanslanmıştır.